$ABVC
Abvc Biopharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Fremont, CA
ABVC chart
What traders are saying about $ABVC
Latest postsAbvc Biopharma, Inc. news
- Attention Deficit Hyperactivity Disorder Pipeline Update 2026: Clinical Development Status, Collaborations, and Key Companies to Watch | Afecta Pharma, ABVC BioPharma, Mind Medicine, Neurocentria
StreetInsider ·
- ABVC BioPharma, Inc. Estimates – NASDAQ:ABVC
TradingView ·
- ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders
Yahoo Finance ·
- ABVC BioPharma Reports 2025 Form 10-K
Yahoo Finance ·
- ABVC BioPharma Provides Corporate and Structural Update
Yahoo Finance ·
- ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States
Yahoo Finance ·
- ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030
Yahoo Finance ·
- ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received
Yahoo Finance ·
- ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million
Yahoo Finance ·
- ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025
Yahoo Finance ·
- ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950
Yahoo Finance ·
Abvc Biopharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $509,589 | $152,430 | $969,783 |
| Net income | -$7.9M | -$4.9M | -$7.8M | -$16.4M |
| Diluted EPS | $-0.39 | $-0.42 | $-1.80 | $-5.19 |
| Total assets (year end) | $21.1M | $7.5M | $7.8M | $9.6M |
| Cash and equivalents (year end) | $681,480 | $248,382 | $60,155 | $85,265 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Abvc Biopharma, Inc.
- Ticker
- ABVC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Fremont, CA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp, METU BRANDS, INC., Ecology Coatings, Inc.
Frequently asked questions
What exchange is Abvc Biopharma, Inc. listed on?
Abvc Biopharma, Inc. trades on the Nasdaq under the ticker symbol ABVC.
What industry is Abvc Biopharma, Inc. in?
Abvc Biopharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Abvc Biopharma, Inc. headquartered?
Abvc Biopharma, Inc.'s business address on file with the SEC is in Fremont, CA.
When does Abvc Biopharma, Inc.'s fiscal year end?
Abvc Biopharma, Inc.'s fiscal year ends on December 31.
How much revenue did Abvc Biopharma, Inc. report?
Abvc Biopharma, Inc. reported $509,589 in revenue for calendar year 2024, according to its SEC filings.